Senseonics, an American company from Maryland has gotten the green light from the relevant authority (the FDA) for its Eversense, a device that monitors glucose in the body.
The system aims to completely replace the classic "finger prick" that diabetics do to evaluate their condition, reducing from a dozen or more measurements to just 2 per day (to calibrate the machine): it is an important step forward, that with a small transmitting system allows you to have 90 days of data at hand (on your mobile phone).
A little friend
Eversense is tiny, 1.8cm by 3.5mm, and takes place under the skin in the position that once marked the vaccinations, the upper part of the arm. On this small basis, the transmitter is placed, which reads the measurements and sends constant updates to the smartphone. If you take a shower, you take it off, if you don't want to take it with you, the sensor keeps recording and when you wear it again it updates you.
Eversense is programmed to alert the wearer when sugar levels drop below the guard level: a providential vibration warns you that you need to run for cover.
"This FDA approval will help diabetic patients dramatically reduce daily discomfort," says Francine R. Kaufman, MD, Endocrinologist and head of the Senseonics medical division.
A great step forward towards total freedom, which one day not far away will allow diabetics to monitor glucose in real time with small implanted devices capable of reading body data by themselves.
Here is the device page: Eversense CGM
